ロード中...
SAFETY EVALUATION OF A LYOPHILIZED PLATELET DERIVED HEMOSTATIC PRODUCT
BACKGROUND: Hemorrhage causes significant morbidity and mortality in persons under 65. A lyophilized platelet-derived hemostatic agent (Thrombosomes) demonstrated hemostatic efficacy in animal models. We report the results of the first safety trial of autologous Thrombosomes given to normal subjects...
保存先:
| 出版年: | Transfusion |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301028/ https://ncbi.nlm.nih.gov/pubmed/30450601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14972 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|